Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» gene therapy
gene therapy
Aiming to be biggest biotech in Boston, Vertex plots 500-person cell, gene therapy R&D center
Fierce Biotech
Fri, 08/4/23 - 12:15 pm
Vertex Pharmaceuticals
cell therapy
gene therapy
R&D
Boston
Sarepta offers early look at closely watched gene therapy launch
BioPharma Dive
Thu, 08/3/23 - 11:19 am
Sarepta Therapeutics
gene therapy
Duchenne Muscular Dystrophy
Elevidys
drug launches
A once buzzy gene therapy startup lays off staff and shuts down
BioPharma Dive
Wed, 08/2/23 - 10:36 pm
Intergalactic Therapeutics
layoffs
gene therapy
Voxzogo saves the day for Biomarin
EP Vantage
Tue, 08/1/23 - 10:05 am
Biomarin
hemophilia A
gene therapy
Roctavian
Voxzogo
AstraZeneca buys Pfizer’s early gene therapy work for up to $1B
BioPharma Dive
Fri, 07/28/23 - 10:45 am
AstraZeneca
Pfizer
M&A
gene therapy
Gene therapy biotech Kriya adds $150M in fresh funds
BioPharma Dive
Wed, 07/26/23 - 06:35 pm
Kriya Therapeutics
gene therapy
funding
A cancer biotech’s collapse gives Neurogene a path to Wall Street
BioPharma Dive
Tue, 07/18/23 - 10:01 pm
Neurogene
gene therapy
reverse merger
Neoleukin
AbbVie, Lilly-backed Capsida cuts staff months after signing Big Pharma deals
Fierce Biotech
Sun, 07/16/23 - 02:37 pm
Capsida Biotherapeutics
layoffs
gene therapy
AbbVie
Eli Lilly
U.S. watchdog lifts price estimate for Bluebird, Vertex/CRISPR gene therapies to $2.1 million
Reuters
Fri, 07/14/23 - 10:07 am
ICER
gene therapy
Vertex Pharmaceuticals
CRISPR Therapeutics
Bluebird Bio
drug pricing
sickle cell disease
Avrobio stops programs, halves head count and searches for exit
Fierce Biotech
Wed, 07/12/23 - 09:41 am
Avrobio
layoffs
gene therapy
Astellas buys rights to 4D Molecular’s technology in latest gene therapy deal
BioPharma Dive
Mon, 07/10/23 - 09:34 pm
Astellas
4D Molecular Therapeutics
gene therapy
viral vectors
BioMarin's hemophilia gene therapy Roctavian lands FDA nod with 'glimmers' of enthusiasm among doctors
Fierce Pharma
Thu, 06/29/23 - 10:56 pm
BioMarin Pharmaceuticall
Roctavian
FDA
hemophilia A
gene therapy
FDA Approves Sarepta’s Gene Therapy for Duchenne Muscular Dystrophy
BioSpace
Thu, 06/22/23 - 10:51 pm
Sarepta Therapeutics
DMD
Duchenne Muscular Dystrophy
FDA
Elevidys
gene therapy
Uniqure’s accelerated approval hopes take a hit
EP Vantage
Thu, 06/22/23 - 10:07 am
uniQure
Huntington's disease
gene therapy
AMT-130
Bluebird, playing catch-up, gets decision date for sickle cell gene therapy
BioPharma Dive
Wed, 06/21/23 - 11:49 am
Bluebird Bio
gene therapy
sickle cell disease
lovo-cel
FDA
Cell and gene therapy manufacturing: the next generation of startups
BioPharma Dive
Tue, 06/20/23 - 11:28 am
cell therapy
gene therapy
ElevateBio
Ascend Gene & Cell Therapies
Shape Therapeutics
Landmark Bio
Vinta Bio
Vector BioMed
startups
Ferring, with manufacturing update, takes a step towards first gene therapy sales
BioPharma Dive
Wed, 06/14/23 - 10:07 am
Ferring Pharmaceuticals
FDA
bladder cancer
gene therapy
Adstiladrin
Charles River Laboratories, Curigin partner on gene therapy
Pharmaceutical Business Review
Tue, 06/13/23 - 10:41 am
Charles River Laboratories
Curigin
gene therapy
RNA
Astellas Partners with Kate Therapeutics in Gene Therapy, After Four Patient Deaths in Previous Trials
BioSpace
Thu, 06/8/23 - 09:54 am
Astellas
Kate Therapeutics
gene therapy
X-linked myotubular myopathy
eXmoor pharma raises $35m to boost cell and gene therapy production
Pharmaceutical Business Review
Wed, 05/31/23 - 10:58 am
eXmoor pharma
funding
cell therapy
gene therapy
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »